1World bank.Global economic prospects and developing countries[M].Washington DC:World bank,1993.
2Arborelius L,Owens M J,Plotsky P M,et al.The role of corticotrophin releasing factor in Depress and anxiety disorder[J].J Endocrinol,1999,160(1):1-12.
3Thrivikraman K V,Nemeroff C B,Plotsky P M.Sensitivity to glucocorticoid mediated fast-feedback regulation of the hypothalamic-pituitary-adrenal axis's dependent upon stressor specific neurocircuitry[J].Brain Res,2000,870(1-2):87-101.
4Koob G F.Corticotropin releasing factor norepinephrine and stress[J].BiolPsychiatry,1999,46(9):1167-80.
5Valentino R J,Lucki I,Van Bockstaele E.Corticotrophin-releasing factor in the dorsal raphe nucleus:Linking stress coping and addiction[J].Brain Res,2010,16(1314):29-37.
6Chernoloz O,El Mansari M,Blier P.Electrophysiological studies in the rat brain on the basis for aripiprazole augmentation of antidepressants in major depressive disorder[J].Psychopharmacology (Berl),2009,206(2):335-44.
2Willner P. Validity, reliability and utility of the chronic mild stress model of depression: a 10 year review and evaluation [J]. Pchopharmacology( Berl), 1997,134:319-329.
3Nowakowska E, Chodera A, Kus K, et al. Reversal of stress-induced memory changes by moclobemide:the role of neurotransmitters [ J]. Pol J Pharmacol,2001,53 ( 3 ) :227. 233.
4.中国药典[S]:一部[M].,2005版.附录ⅫE,附65.
5Legutko B,Li X,Skolnick P.Regulation of BDNF expression in primary neuron culture by LY392098,a novel AMPA receptor potentiator[J].Neuropharmacology,2001,40(8):1019-27.
6Svenningsson P,Tzavara E T,Witkin J M,et al.Involvement of striatal and extrastriatal DARPP-32 in biochemical and behavioral effects of fluoxetine(prozac)[J].Proc Natl Acad Sci USA,2002,99(5):3182 -7.
7Matrisciano F,Scaccianoce S,Del Bianco P,et al.Metabotropic glutamate receptors and neuroadaptation to antidepressants:imipramine induced down-regulation of beta-adrenergic receptors in mice treated with metabotropic glutamate 2/3 receptor ligands[J].J Neurochem,2005,93 (5):1345-52.
8Fiebich B L,Hollig A,Lieb K.Inhibition of substance P-induced cytokine syuthesis by St.John's wort extracts[J].Pharmacopsychiatry,2001,34(suppl 1):26-8.
9Kramer M S,Winokur A,Kelsey J,et al.Demonstration of the efficacy and safety of a novel substance P(NK1) receptor antagonist in major depression[J].Neuro Psychopharmacol,2004,29(2):385 -92.
10Czeh B,Simon M,Hart M G,et al.Chronic stress decreases the number of parvalbu-min-immunoreactive interneurons in the hippocampus prevention by treatment with a substance P receptor(NK1)antagonist[J].Neuro Psychopharmacol,2005,30 (1):67-79.
